- Empower Clinics (CBDT) has rebranded of its medical diagnostics laboratory business in the U.S. to Medisure Laboratory
- The new brand marks an important milestone in the evolution of Empower’s presence in the U.S. healthcare market
- Chairman & CEO Steven McAuley sat down with Sabrina Cuthbert to discuss the news
- Empower is an integrated healthcare company that provides digital and telemedicine care
- Empower Clinics Inc. (CBDT) opened trading at C$0.08 per share
Empower Clinics (CBDT) has rebranded its medical diagnostics laboratory business in the U.S. to Medisure Laboratory.
The new brand marks an important milestone in the evolution of Empower’s presence in the U.S. healthcare market, providing access to the largest hospital networks with laboratory services in the state of Texas, the cruise ship industry, and film & television productions.
Steven McAuley, Chairman and CEO of Empower Clinics, sat down with Sabrina Cuthbert to highlight the updates.
“The Medisure brand is strong, and embodies the energy and growth that we have for our business in the U.S. market. Launching Medisure Labs in the U.S. and utilizing our investments just makes sense, it opens new doors, allows us to bring products to market and grow more rapidly. With Medisure Labs, we have a proven brand serving many thousands of patients, that is primed to succeed in the world’s largest healthcare market.”
Immediate plans for Medisure include researching, applying for and securing additional U.S. Federal Drug and Administration (FDA) certifications to allow for the sale of its medical devices in the U.S.
Empower is an integrated healthcare company that provides body and mind wellness for patients through its clinics, with digital and telemedicine care, a medical device company and world-class medical diagnostics laboratories. Empower is aggressively growing its clinical and digital presence across North America.
Empower Clinics Inc. (CBDT) opened trading at C$0.08 per share.